BamSEC and AlphaSense Join Forces
Learn More

Ardelyx Inc.

NASDAQ: ARDX    
Share price (1/7/25): $5.41    
Market cap (1/7/25): $1.281 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.6
from 10-Q 2 pages July 25, 2024 Eric Foster Dear Eric,
12/34/56
EX-10.2
from 10-Q 38 pages Commercial Supply Agreement
12/34/56
EX-10.2
from 8-K 5 pages Sixth Amendment to Lease
12/34/56
EX-10.1
from 8-K 57 pages Lease by and Between Bmr-Pacific Research Center LP, a Delaware Limited Partnership and Ardelyx, Inc., a Delaware Corporation
12/34/56
EX-10.1
from 8-K 46 pages Commercial Supply Agreement Tenapanor Hydrochloride Tablets
12/34/56
EX-10.2
from 10-Q 14 pages Ardelyx, Inc. Amended and Restated 2014 Employee Stock Purchase Plan
12/34/56
EX-10.1
from 10-Q 33 pages Ardelyx, Inc. Amended and Restated 2014 Equity Incentive Award Plan Article 1. Purpose
12/34/56
EX-10.2
from 8-K 33 pages Ardelyx, Inc. Amended and Restated 2014 Equity Incentive Award Plan Article 1. Purpose
12/34/56
EX-10.1
from 8-K 14 pages Ardelyx, Inc. Amended and Restated 2014 Employee Stock Purchase Plan
12/34/56
EX-10.29
from 10-Q 2 pages February 13, 2024 Michael Kelliher
12/34/56
EX-10.3(C)
from 10-Q 4 pages Third Amendment to Commercial Lease
12/34/56
EX-10.3(B)
from 10-Q 4 pages Second Amendment to Commercial Lease
12/34/56
EX-10.20(B)
from 10-K 3 pages Ardelyx, Inc. Third Amended and Restated Non-Employee Director Compensation Program
12/34/56
EX-10.7(A)
from 10-K 19 pages Ardelyx, Inc. 2016 Employment Commencement Incentive Plan Article 1. Purpose
12/34/56
EX-10.27(B)
from 10-K 3 pages First Amendment to Manufacturing Services Agreement Between Ardelyx, Inc. and Patheon Pharmaceuticals Inc
12/34/56
EX-10.21(B)
from 10-K 2 pages Amendment No. 1 to License Agreement
12/34/56
EX-10.2(E)
from 10-K 4 pages Fourth Amendment to Lease
12/34/56
EX-10.3
from 10-Q 3 pages Ardelyx, Inc. Second Amended and Restated Non-Employee Director Compensation Program
12/34/56
EX-10.1
from 10-Q 57 pages Royalty and Sales Milestone Interest Acquisition Agreement Dated as of June 29, 2022 Between Ardelyx, Inc. and Healthcare Royalty Partners IV, L.P
12/34/56
EX-10.2
from 10-Q 5 pages Exit Fee Agreement
12/34/56